Although the higher HDAC2 expression associated with CRC found in the TMA analysis is not always reflected in our in silico results, we hypothesize that HDAC2 acts as a double-edged sword depending on its expression and the immunological context. Here, HDAC2 is linked to colorectal carcinoma.